Betrachtungen zu einer möglichen Neuregulierung der Cannabispolitik in Deutschland unter Berücksichtigung der Erfahrungen aus den Niederlanden und Colorado

Peter Neu

doi:10.1055/s-0044-100504

Fortschritte der Neurologie · Psychiatrie, Table of Contents

Fortschr Neurol Psychiatr 2018; 86(07): 428-433
DOI: 10.1055/s-0044-100504

Übersicht

Betrachtungen zu einer möglichen Neuregulierung der Cannabispolitik in Deutschland unter Berücksichtigung der Erfahrungen aus den Niederlanden und Colorado

Discussing possible new regulations in german cannabis policy with special regard to the experiences in the Netherlands and Colorado

Peter Neu

Jüdisches Krankenhaus Berlin Akademisches Lehrkrankenhaus der Charite – Universitätsmedizin Berlin

› Author Affiliations

Abstract

Zusammenfassung

In Deutschland wird seit einiger Zeit zunehmend über eine neue Cannabispolitik nachgedacht. Von vielen Seiten wird die Forderung nach einer Liberalisierung oder Freigabe des Cannabis laut. Der vorliegende Artikel fasst die wichtigsten Erfahrungen der Cannabis-Politik aus den Niederlanden und dem US-Bundesstaat Colorado zusammen und versucht, daraus Schlussfolgerungen für eine mögliche Neuregulierung der Cannabispolitik in Deutschland abzuleiten.

Abstract

For quite a while a discussion has been taking place in Germany whether or not cannabis should be legalized. This article summarizes the experiences of the Dutch coffee shop system and legalization of cannabis use for recreational purposes in Colorado and attempts to derive recommendations for a cannabis policy in Germany.

Schlüsselwörter

Cannabis - Liberalisierung - Deutschland - Niederlande - Colorado

Key words

liberalization - Germany - Netherlands - Colorado - cannabis

Full Text

References

Literatur
1 McGinty EE, Niederdeppe J, Heley K. et al. Public perceptions of arguments supporting and opposing recreational marijuana legalization. Prev Med 2017; 99: 80-86
2 Monshouwer K, van Laar K, Vollebergh WA. Buying cannabis in coffee shops. Drug and Alcohol Review 2011; 30: 148-156
3 McCoun R. In what sense (if any) is marijuana a gateway drug? Drug Policy Anal Bull 1998; 4: 5-8
4 Monshouwer K, van Laar K, Vollebergh WA. Buying cannabis in coffee shops. Drug and Alcohol Review 2011; 30: 148-156
5 McCoun RJ. What can we learn from the Dutch cannabis coffeeshop system? Addiction 2011 106. 1899-1910
6 Bieleman B, Beelen A, Nijkamp R. et al. Coffee shops in the Netherlands 2007. Number of coffee shops and local policies 1999–2007. Groningen: WODC/St. Intraval; 2008
7 Monshouwer K, van Laar K, Vollebergh WA. Buying cannabis in coffee shops. Drug and Alcohol Review 2011; 30: 148-156
8 Bieleman B, Beelen A, Nijkamp R. et al. Coffee shops in the Netherlands 2007. Number of coffee shops and local policies 1999–2007. Groningen: WODC/St. Intraval; 2008
9 Reinarman C, Cohen PDA, Kaal HL. The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco. Am J Public Health 2004; 94: 836-42
10 Simons-Morton B, Pickett W, Boyce W. et al. Cross-national comparison of adolescent drinking and cannabis use in the United States, Canada and the Netherlands. International Journal of Drug Policy 2010; 21: 64-69
11 MacCoun RJ. What can we learn from the Dutch cannabis coffeeshop system? Addiction 2011; 106: 1899-1910
12 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Stat Bull 2009 Available at: http://www.emcdda.europa.eu/stats09 (accessed 1 August 2011; archived by Webcite at. http://www.webcitation.org/60cQYIPPY).
13 European School Survey Project on Alcohol and Other Drugs (ESPAD). The 2007 ESPAD Report. Av. at http://www.espad.org/documents/Espad/ESPAD_reports/2007/The_2007_ESPAD_Report-FULL_091006.pdf (accessed 1 August 2011; archived by Webcite at. http://www.webcitation.org/60cQwFaQL).
14 Gosh TS, Van Dyke M, Maffey A. et al. Medical Marijuana´s Public Health Lessons – Implication for Retail Marijuana in Colorado. New Engl J Med 2015; 372 (11) 991-993
15 Colorado Department of Revenue Enforcement Division https://www.colorado.gov/pacific/revenue/colorado-marijuana-tax-data (letzter Zugriff 04.04.2017)
16 Marijuana Enforcement Division. Permanent Rules Related to the Colorado Retail Marijuana Code. East Lansing, MI:Marijuana Enforcement Division 2013
17 Marijuana Enforcement Division. Permanent Rules Related to the Colorado Retail Marijuana Code. East Lansing, MI: Marijuana Enforcement Division 2013
18 Olson B. `Chart of the Week: 60% of Cannabis Companies don´t have Bank accounts.` Marijuana Business Daily ( 2015 , December 14 ) abgerufen im Internet http://mjbizdaily.com/chart-week-60-cannabis-companies-dont-bank-accounts/ (letzter Zugriff 04.04.2017).
19 Hughes T. Federal bankers: No account for Colo. cannabis credit union. USA Today ( 2015 July 31 ) abgerufen im Internet: https://www.usatoday.com/story/money/business/2015/07/31/federal-bankers-no-account-colo-cannabis-credit-union/30943749/ (letzter Zugriff 04.04.2017). .
20 Gosh TS, Van Dyke M, Maffey A. et al. Medical Marijuana´s Public Health Lessons – Implication for Retail Marijuana in Colorado. New Engl J Med 2015; 372 (11) 991-993
21 Stone D. Cannabis, pesticides and conflicting laws: The dilemma for legalized states and implications for public health. Regulatory Toxicology and Pharmacology 2014; 69 (03) 284-288
22 Stone D. Cannabis, pesticides and conflicting laws: The dilemma for legalized states and implications for public health. Regulatory Toxicology and Pharmacology 2014; 69 (03) 284-288
23 Ghosh TS, Vigil DI, Maffey A. et al. Lessons learned after three years of legalized, recreational marijuana: The Colorado experience. Prev Med 2017 http://dx.doi.org/10.1016/j.ypmed.2017.02.021
24 Kim HS, Hall KE, Genco EK. et al. Marijuana tourism and emergency department visits in Colorado. N Engl J Med 2016; 374 (08) 797-798
25 Ghosh T, Van Dyke M, Maffey A. et al. The Public Health Framework of Legalized Marijuana in Colorado. Am J Public Health 2016; 106: 21-27
26 Moore THM, Zammit S, Lingford-Hughes A. et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 2007; 370: 319-328
27 Stefanis NC, Dragovic M, Power BD. et al. Age at initiation of cannabis use predicts age at onset of psychosis: the 7-to-8-year-trend. Schizophr Bull 2013; 39 (02) 251-254
28 Stepniak B, Papiol S, Hammer C. et al. Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based study. Lancet Psychiatry 2014; Nov 1 (06) 444-53
29 Rounsaville BJ. DSM-V research agenda: substance abuse/psychosis comorbidity. Schizophr Bull 2007; 33 (04) 947-52
30 Murray RM, Quigley H, Quattrone D. et al. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry Oct 2016; 15 (03) 195-204
31 Mortler M. Drogen- und Suchtbericht der Beauftragten der Bundesregierung, Juli 2014
32 Ghosh TS, Vigil DI, Maffey A, Tolliver R, Van Dyke M, Kattari L, Krug H, Reed JK, Wolk L. ( 2017 ) Lessons learned after three years of legalized, recreational marijuana: The Colorado experience. Prev Med http://dx.doi.org/10.1016/j.ypmed.2017.02.021
33 McCoun RJ. What can we learn from the Dutch cannabis coffeeshop system? Addiction 2011 106. 1899-1910
34 Pacula RL, Kilmer B, Wagenaar AC. et al. Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am J Public Health 2014; 104: 1021-28
35 Shanahan M, Ritter A. Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation. PLoS ONE 2014; 9 (04) e95569 doi:10.1371/journal.pone.0095569
36 Shanahan M, Ritter A. Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation. PLoS ONE 2014; 9 (04) e95569 doi:10.1371/journal.pone.0095569
37 Englund A, Freeman TP, Murray RM. et al. Can we make cannabis safer? Lancet Psychiatry 2017 Mar 1. pii: S2215-0366(17)30075-5. doi: 10.1016/S2215-0366(17)30075-5. [Epub ahead of print] Review
38 Shanahan M, Ritter A. Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation. PLoS ONE 2014; 9 (04) e95569 doi:10.1371/journal.pone.0095569